The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for neuropathic pain treatment. This patent is set to remain in effect until at ...

President Trump proposes U.S. oversight of Gaza post-conflict, emphasizing development while downplaying military involvement. Regional partners may aid refugee resettlement.